A PROBABILITY ESTIMATOR FOR wtATTR-CM

Pfizer’s novel prediction model, derived from machine learning, shows robust performance for identifying heart failure patients who are at-risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, a rare and life-threatening condition